Acadia Healthcare (ACHC) versus China Cord Blood Corporation (CO) Head-To-Head Review
Acadia Healthcare (NASDAQ: ACHC) and China Cord Blood Corporation (NYSE:CO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.
Earnings and Valuation
This table compares Acadia Healthcare and China Cord Blood Corporation’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Acadia Healthcare||$2.83 billion||1.45||$574.61 million||$0.09||519.78|
|China Cord Blood Corporation||$122.77 million||11.04||$52.40 million||$0.29||41.17|
Acadia Healthcare has higher revenue and earnings than China Cord Blood Corporation. China Cord Blood Corporation is trading at a lower price-to-earnings ratio than Acadia Healthcare, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Acadia Healthcare has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500. Comparatively, China Cord Blood Corporation has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500.
This is a summary of current ratings for Acadia Healthcare and China Cord Blood Corporation, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|China Cord Blood Corporation||0||0||0||0||N/A|
Acadia Healthcare currently has a consensus target price of $59.09, suggesting a potential upside of 26.32%. Given Acadia Healthcare’s higher possible upside, equities analysts plainly believe Acadia Healthcare is more favorable than China Cord Blood Corporation.
This table compares Acadia Healthcare and China Cord Blood Corporation’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|China Cord Blood Corporation||22.07%||8.64%||3.50%|
Institutional & Insider Ownership
13.3% of China Cord Blood Corporation shares are held by institutional investors. 11.1% of Acadia Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Acadia Healthcare beats China Cord Blood Corporation on 9 of the 14 factors compared between the two stocks.
About Acadia Healthcare
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities. The Company is engaged in operating acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers and facilities providing outpatient behavioral healthcare services. As of December 31, 2016, the U.S. Facilities segment included 208 behavioral healthcare facilities with approximately 8,500 beds in 39 states and Puerto Rico, and the U.K. Facilities segment included 365 behavioral healthcare facilities with approximately 8,600 beds in the United Kingdom. As of December 31, 2016, the Company had operated 573 behavioral healthcare facilities with approximately 17,100 beds in 39 states, the United Kingdom and Puerto Rico.
About China Cord Blood Corporation
China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.